Modulation of POMC expression in human neuroectodermal cells

Biochem Biophys Res Commun. 1993 Dec 30;197(3):1402-9. doi: 10.1006/bbrc.1993.2633.

Abstract

Neuroblastoma cell lines have been reported to contain two proopiomelanocortin (POMC) mRNA transcripts. We have now shown by immunocytochemistry and radioimmunoassay (RIA) that a number of neuroectodermally derived cell lines contain immunoreactive beta-endorphin although cell concentrations were not characteristic of any tumour type. To explore further the functional significance of beta-endorphin expression, we analysed neuroblastoma cell lines having intermediate (I), substrate adherent (S) and neuronal (N) phenotypes. No differences in cell beta-endorphin content were detected. However, the expression of POMC mRNA and of immunoreactive beta-endorphin was reduced within a few hours of treatment of these cell lines with retinoic acid. Culture of the cell lines in the presence of beta-endorphin resulted in small but significant increases in growth. Although the POMC gene is in the same chromosomal segment as N-myc, which is normally amplified in neuroblastoma, no corresponding amplification of POMC could be demonstrated. The data suggest that POMC gene products may contribute to the autocrine/paracrine growth of neuroectodermal tumours.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Clone Cells
  • Ectoderm
  • Gene Expression* / drug effects
  • Glioblastoma
  • Humans
  • Immunohistochemistry
  • Melanoma
  • Neuroblastoma
  • Neuroectodermal Tumors, Primitive, Peripheral
  • Pro-Opiomelanocortin / analysis
  • Pro-Opiomelanocortin / biosynthesis*
  • RNA, Messenger / biosynthesis
  • Radioimmunoassay
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured
  • beta-Endorphin / analysis
  • beta-Endorphin / biosynthesis

Substances

  • RNA, Messenger
  • Tretinoin
  • beta-Endorphin
  • Pro-Opiomelanocortin